Trastuzumab-associated autoimmune thyroid disease in a patient with metastatic breast cancer
Hong Ki Min, In-Ho Kim, Jae Young Kim, Tae-hyun Ban, Kyung Hoon Kim, Jeonghoon Ha, Jung-Hoon Kim
Korean J Intern Med. 2016;31(3):608-611.   Published online 2016 Feb 18     DOI: https://doi.org/10.3904/kjim.2014.031
Citations to this article as recorded by Crossref logo
Influence of the anti‐oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review
Djordje Marina, Åse Krogh Rasmussen, Kristian Buch‐Larsen, Linn Gillberg, Michael Andersson, Peter Schwarz
Cancer Medicine.2023; 12(2): 967.     CrossRef
Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer
Chinmeri U. Achonu, Oluwarotimi B. Olopade, Bashir O. Yusuf, Abimbola A. Fadeyi, Olufemi A. Fasanmade
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.2023; 42(6): 194.     CrossRef
Expression of Thyroid Peroxidase Antibody, Thyroglobulin Antibody, and Thyrotropin Receptor Antibody in Breast Cancer and Their Associations with Clinical Characteristics of Breast Cancer
Xiaoyi Liu, Zhengju Fu, Hongmei Xu, Kui Che, Jingwei Chi, Jianxia Hu
Indian Journal of Surgery.2022; 84(S3): 619.     CrossRef
Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
Alexander Y. Deneka, Yanis Boumber, Tim Beck, Erica A. Golemis
Cancers.2019; 11(9): 1297.     CrossRef
Trastuzumab
Reactions Weekly.2016; 1603(1): 240.     CrossRef